The progression of atherosclerosis in people who have no symptoms of it is independently associated with the risk of dying from any cause, according to a new study led by researchers from Mount Sinai Fuster Heart Hospital, published September 30 in the Journal of the American College of Cardiology.
Prevymis wins CHMP nod for CMV disease in kidney transplant patients – Pharmaceutical Technology
The CHMP decision could now expand the approval to patients at risk of CMV infection during kidney transplants in the EU. Image credit: Shutterstock/Explode. The
October 18, 2023